The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma
Ewing sarcoma (ES) is a rare, highly aggressive, bone, or soft tissue-associated tumor. Although this sarcoma often responds well to initial chemotherapy, 40% of the patients develop a lethal recurrence of the disease, with death recorded in 75–80% of patients with metastatic ES within 5 years, desp...
Main Author: | Wook Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00613/full |
Similar Items
-
MicroRNAs in Ewing Sarcoma
by: Layne eDylla, et al.
Published: (2013-03-01) -
Role of fluoroethyl tyrosine positron emission tomography-computed tomography scan in differentiating ewing's sarcoma from osteomyelitis
by: Hitesh Aggarwal, et al.
Published: (2019-01-01) -
Sarcoma de Ewing en paciente masculino Ewing's sarcoma in a male patient
by: Eddy Millán Escalona, et al.
Published: (2010-09-01) -
Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment
by: Ramona Palombo, et al.
Published: (2020-01-01) -
Ewing`s Sarcoma
by: Agnieszka Budny, et al.
Published: (2017-06-01)